Predictors of outcome in paediatric IgA nephropathy with regard to clinical and histopathological variables (Oxford classification)

Nephrology Dialysis Transplantation

Volumn 27, Issue 2, 2012, Pages 715-722

  Edström Halling, Stella ^a   Söderberg, Magnus P ^a   Berg, Ulla B ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

glomerular filtration rate; IgA nephropathy; Oxford classification; predictors; proteinuria

Indexed keywords

ALBUMIN; ANGIOTENSIN RECEPTOR ANTAGONIST; CORTICOSTEROID; CREATININE; CYCLOPHOSPHAMIDE; DIPEPTIDYL CARBOXYPEPTIDASE; IMMUNOGLOBULIN A; INULIN; IOHEXOL;

ADOLESCENT; ALBUMINURIA; ARTICLE; BLOOD PRESSURE MEASUREMENT; CHILD; CLINICAL INDICATOR; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; KIDNEY CLEARANCE; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; OUTCOME ASSESSMENT; OXFORD CLASSIFICATION; PREDICTIVE VALUE; PREDICTOR VARIABLE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEINURIA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RETROSPECTIVE STUDY; SCHOOL CHILD; TREATMENT OUTCOME;

ADOLESCENT; AGE FACTORS; ANALYSIS OF VARIANCE; BIOPSY, NEEDLE; BLOOD PRESSURE DETERMINATION; CHI-SQUARE DISTRIBUTION; CHILD; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; GLOMERULAR FILTRATION RATE; GLOMERULONEPHRITIS, IGA; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; KIDNEY FAILURE, CHRONIC; MALE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROTEINURIA; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX FACTORS; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84856912668     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr339     Document Type: Article

References (24)

1. Coppo R, D'Amico G. Factors predicting progression of IgA nephropathies. J Nephrol 2005; 18: 503-512
2. D'Amico G. Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. Semin Nephrol 2004; 24: 179-196
3. Wyatt RJ, Kritchevsky SB, Woodford SY et al. IgA nephropathy: long-term prognosis for pediatric patients. J Pediatr 1995; 127: 913-919
4. Ronkainen J, Ala-Houhala M, Autio-Harmainen H et al. Long-term outcome 19 years after childhood IgA nephritis: a retrospective cohort study. Pediatr Nephrol 2006; 21: 1266-1273
5. Yoshikawa N, Tanaka R, Iijima K. Pathophysiology and treatment of IgA nephropathy in children. Pediatr Nephrol 2001; 16: 446-457
6. Lee SM, Rao VM, Franklin WA et al. IgA nephropathy: morphologic predictors of progressive renal disease. Hum Pathol 1982; 13: 314-322
7. Haas M. Histologic subclassification of IgA nephropathy: a clinicopathologic study of 244 cases. Am J Kidney Dis 1997; 29: 829-842
8. Cattran DC, Coppo R, Cook HT et al. The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int 2009; 76: 534-545
9. Roberts IS, Cook HT, Troyanov S et al. The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int 2009; 76: 546-556
10. Coppo R, Troyanov S, Camilla R et al. The Oxford IgA nephropathy clinicopathological classification is valid for children as well as adults. Kidney Int 2010; 77: 921-927
11. Berg UB, Back R, Celsi G et al. Comparison of plasma clearance of iohexol and urinary clearance of inulin for measurement of GFR in children. Am J Kidney Dis 2010; doi:10.1053/j.ajkd.2010.07.013
12. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004; 114 (2 Suppl) 4th Report: 555-576
13. Goto M, Kawamura T, Wakai K et al. Risk stratification for progression of IgA nephropathy using a decision tree induction algorithm. Nephrol Dial Transplant 2009; 24: 1242-1247
14. Bartosik LP, Lajoie G, Sugar L et al. Predicting progression in IgA nephropathy. Am J Kidney Dis 2001; 38: 728-735
15. Hogg RJ, Silva FG, Wyatt RJ et al. Prognostic indicators in children with IgA nephropathy-report of the Southwest Pediatric Nephrology Study Group. Pediatr Nephrol 1994; 8: 15-20
16. Geddes CC, Rauta V, Gronhagen-Riska C et al. A tricontinental view of IgA nephropathy. Nephrol Dial Transplant 2003; 18: 1541-1548
17. Cattran DC, Greenwood C, Ritchie S. Long-term benefits of angiotensin-converting enzyme inhibitor therapy in patients with severe immunoglobulin a nephropathy: a comparison to patients receiving treatment with other antihypertensive agents and to patients receiving no therapy. Am J Kidney Dis 1994; 23: 247-254
18. Ibels LS, Gyory AZ, Caterson RJ et al. Recognition and management of IgA nephropathy. Drugs 1998; 55: 73-83
19. Reich HN, Troyanov S, Scholey JW et al. Remission of proteinuria improves prognosis in IgA nephropathy. J Am Soc Nephrol 2007; 18: 3177-3183
20. Haas M, Rahman MH, Cohn RA et al. IgA nephropathy in children and adults: comparison of histologic features and clinical outcomes. Nephrol Dial Transplant 2008; 23: 2537-2545
21. Edstrom Halling S, Soderberg MP, Berg UB. Treatment of severe Henoch-Schonlein and immunoglobulin A nephritis. A single center experience. Pediatr Nephrol 2009; 24: 91-97
22. Berg UB, Bohman SO, Widstam-Attorps U. Renal histological changes in relation to renal function and urinary protein excretion in IgA nephropathy. Arch Dis Child 1991; 66: 593-597
23. Walsh M, Sar A, Lee D et al. Histopathologic features aid in predicting risk for progression of IgA nephropathy. Clin J Am Soc Nephrol 2010; 5: 425-430
24. Yata N, Nakanishi K, Shima Y et al. Improved renal survival in Japanese children with IgA nephropathy. Pediatr Nephrol 2008; 23: 905-912